Exponent (NASDAQ:EXPO) executives highlighted a “strong finish” to fiscal 2025, pointing to broad-based demand across ...
Q4 2025 Management View CEO Catherine Corrigan reported a strong close to 2025, highlighting "growth in proactive engagements, driven by increased demand for user research in consumer electronics, ...
Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the fourth quarter and fiscal year 2025 ended January 2, ...
Scientific consulting firm Exponent (NASDAQ:EXPO) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with ...
Scientific consulting firm Exponent (NASDAQ:EXPO) reported Q2 CY2025 results exceeding the market’s revenue expectations , with sales up 7.2% year on year to $142 million. On the other hand, next ...
Exponent is a business that we have admired from the sidelines for a while, and we finally saw an opportunity to initiate a position at an attractive price due to a rare pause in annual growth. No ...
Exponent is a leading provider of multidisciplinary consulting services, leveraging scientific and engineering expertise to address critical technical and regulatory challenges for clients worldwide.